NONCLASSICAL ANTIMETABOLITES. XIV. SOME FACTORS IN DESIGN OF IRREVERSIBLE INHIBITORS EFFECTIVE AT LOW CONCENTRATION.
D000963:Antimetabolites; D002626:Chemistry, Pharmaceutical; D003374:Coumarins; D004791:Enzyme Inhibitors; D006571:Heterocyclic Compounds; D007770:L-Lactate Dehydrogenase; D010088:Oxidoreductases; D010604:Pharmacy; D011804:Quinolines; D012106:Research; D020156:Salicylic Acid
D000963:Antimetabolites; D003374:Coumarins; D004791:Enzyme Inhibitors; D006571:Heterocyclic Compounds; D011804:Quinolines; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D020156:Salicylic Acid
ANTIMETABOLITES; CHEMISTRY, PHARMACEUTICAL; COUMARINS; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; HETEROCYCLIC COMPOUNDS; LACTATE DEHYDROGENASE; OXIDOREDUCTASES; QUINOLINES; SALICYLIC ACID